Position in IMVT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,043,240
+$4,201,279 QoQ
Shares Held
203,029
+513.0% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026XTX Topco Ltd holds $273,632,841 across 373 Biotechnology names. IMVT ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
255,431 | $7,075,438 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,632 | $6,980,313 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
80,519 | $6,046,171 | |
| 4 | EXEL |
Exelixis, Inc.
|
134,413 | $5,764,973 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
160,880 | $5,442,570 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
93,609 | $5,287,972 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
59,502 | $5,174,888 | |
| 8 | IMVT |
Immunovant, Inc.
This page
|
203,029 | $5,043,240 |
All Filings in IMVT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,043,240 | 203,029 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $841,961 | 33,122 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $279,311 | 17,327 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,299,008 | 81,188 | Shares | Defined | 2025-08-12 | |
| 2024-12-31 | $563,269 | 22,740 | Shares | Defined | 2025-02-13 | |
| 2024-03-31 | $298,447 | 9,237 | Shares | Defined | 2024-05-13 | |
| 2023-03-31 | $318,699 | 20,548 | Shares | Defined | 2023-05-12 | |
| 2021-09-30 | $133,982 | 15,418 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||